NFE2L2 and Alzheimer disease: The substance 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid-methyl amide (CDDO-MA), an Nrf2–ARE pathway activator, has been demonstrated to improve cognition and reduce plaque development, Aβ, and OS indicators in Tg19959 transgenic AD mice.